<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The growth of 66 long-term survivors, transplanted in two centres (Genoa S </plain></SENT>
<SENT sid="1" pm="."><plain>Martino and Monza) is reported </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were <z:hpo ids='HP_0000001'>all</z:hpo> under age 15 at the time of bone marrow transplantation (mean 9.8 +/- 3.4 years; range 1.07-15 years) with a minimum follow-up of at least 12 months </plain></SENT>
<SENT sid="3" pm="."><plain>They were divided into four groups </plain></SENT>
<SENT sid="4" pm="."><plain>Group 1: eight patients with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA): conditioning included <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (CY) 200 mg/kg only </plain></SENT>
<SENT sid="5" pm="."><plain>Group 2: 32 patients with <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL), and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>): conditioning included CY 120 mg/kg and 10-12 Gy fractionated total body irradiation (fTBI) </plain></SENT>
<SENT sid="6" pm="."><plain>Group 3: 20 patients with ALL, who had previously received cranial irradiation; conditioning included CY 120 mg/kg and fTBI with an additional testicular irradiation (4 Gy) </plain></SENT>
<SENT sid="7" pm="."><plain>Group 4: six patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>; conditioning included CY 200 mg/kg and <z:chebi fb="0" ids="28901">busulfan</z:chebi> (BU) 16 mg/kg </plain></SENT>
<SENT sid="8" pm="."><plain>Group was impaired in <z:hpo ids='HP_0000001'>all</z:hpo> four groups, including the unirradiated groups (-0.2 +/- 0.7 and -0.5 +/- 0.6 delta-<z:chebi fb="26" ids="8984">SDS</z:chebi> in groups I and 4, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>Growth impairment-<z:chebi fb="26" ids="8984">SDS</z:chebi> was statistically significant in the two irradiated groups (-0.7 +/- 1.0 and -0.9 +/- 1.0 delta-<z:chebi fb="26" ids="8984">SDS</z:chebi> in groups 2 and 3, respectively), more marked in patients who had had previous cranial irradiation </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0018133" disease_type="Disease or Syndrome" abbrv="GVH">graft-versus-host disease</z:e> and its treatment were not found to have a major effect on growth </plain></SENT>
</text></document>